| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Sagimet Biosciences Inc.
13G/A
SGMT · 786700104
|
4.9% |
6/24/2025
Event 6/24/2025
|
||||
| AP11 Limited | 4.9% | |||||
| Ascletis Pharma Inc. | 4.9% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.